Nordicus Partners Corporation

Nordicus Partners Corporation

NORD

NASDAQHealthcareBiotechnology

GoAI で開く

最新データ

$2.80

−$0.13 · -4.44%

NORDの企業概要

日中の時刻はETです。市場データは遅延する場合があります。

企業プロフィール

会社ウェブサイト

Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.

業界
Biotechnology
セクター
Healthcare
本社
US
最高経営責任者(CEO)
Henrik Rouf
上場以来
1996年6月12日
従業員
15

市場での位置

日中レンジ

現在 $2.80

52週レンジ

現在 $2.80

始値
$2.50
前日終値
$2.93
出来高
4716
0.73× 平均
平均出来高
6441
1日平均出来高
時価総額
5444.29万 USD
ベータ
-0.7
市場参照 1
50日平均
$3.6086
平均以下(-22.41%)
200日平均
$3.5019
平均以下(-20.04%)
読み込み中